Valeant Pharma (VRX) calls active as shares sell off 7.8%
Tweet
Share
E-mail
Valeant Pharma (NYSE: VRX) call put ratio 1.9 calls to 1 put with focus on June weekly and July 25 calls as shares sell off 7.8% after receiving Complete Response Letter from FDA
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump: We May Hit Pickaxe Very Soon
- FDA approves Ionis Pharma's therapy to treat rare genetic disorder
- Active options: AMD META SMCI GOOGL SNDK AVGO PLTR NFLX LULU MSFT IREN HOOD
Create E-mail Alert Related Categories
Options, Trader TalkRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
